RemeGen Co., Ltd. (HKG:9995)
68.20
+5.65 (9.03%)
Nov 4, 2026, 1:50 PM HKT
RemeGen Employees
RemeGen had 3,145 employees as of June 30, 2026. That makes RemeGen the 7,687th largest employer in the world and 591st in Hong Kong.
Employees
3,145
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
3.18M HKD
Profits / Employee
2.51M HKD
Market Cap
52.64B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 3,145 | - | - |
| Dec 31, 2025 | 3,048 | 49 | 1.63% |
| Dec 31, 2024 | 2,999 | -616 | -17.04% |
| Dec 31, 2023 | 3,615 | 283 | 8.49% |
| Dec 31, 2022 | 3,332 | 1,211 | 57.10% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sino Biopharmaceutical | 22,838 |
| Genscript Biotech | 6,135 |
| 3SBio | 6,068 |
| Akeso | 4,082 |
| Shanghai Henlius Biotech | 4,082 |
| Shanghai Junshi Biosciences | 3,055 |
| Sichuan Kelun-Biotech Biopharmaceutical | 2,300 |
| Biocytogen Pharmaceuticals (Beijing) | 1,922 |
RemeGen News
- 5 days ago - RemeGen Earnings release: Q3 2026 - Filings
- 5 days ago - RemeGen Slides: Q3 2026 - Filings
- 5 weeks ago - Vor Bio announces new post hoc analysis from Phase 3 trial on telitacicept - TheFly
- 2 months ago - RemeGen Earnings release: Q2 2026 - Filings
- 2 months ago - RemeGen Quarterly report: Q2 2026 - Filings
- 6 months ago - RemeGen Earnings release: Q1 2026 - Filings
- 7 months ago - RemeGen Annual report: Q4 2025 - Filings
- 7 months ago - RemeGen Slides: Q4 2025 - Filings